Almaarefa University
The authoritative source for research information and outputs is Elsevier Scopus, with researcher profile verification from the Deanship of Scientific Research.

المخرجات

Research outputs

Articles, reviews, conference papers and book chapters, indexed by DOI and linked to University researchers.

30 output Results for «Randomized controlled trial»

ArticleOpen access20262citation· Semantic Scholar

High-intensity versus low-intensity laser acupuncture in chronic, non-specific low back pain: a double-blinded, randomized controlled trial

Frontiers in Medicine · vol. 13 · 1857622-1857622

Background: Chronic nonspecific low back pain (CNSLBP) is a musculoskeletal condition characterized by persistent discomfort, weak trunk muscles, exhaustion, and disability. Objectives: The purpose of this study is to compare the effects of high-intensity laser acupuncture (HILA) and low-intensity laser acupuncture (LILA), combined with exercise, on strength of trunk extensors, fatigue, level of pain, range of motion (ROM) of lumbar flexion, and disability in patients with CNSLBP. Materials and methods: 60 participants with CNSLBP were divided into three groups in this randomized, double-blind, sham-controlled trial: the high-intensity laser (HILA) group, who received HILA over 15 acupuncture points along with exercises; the low-intensity laser (LILA) group, who received LILA over the same points plus exercises; and the sham group, who received sham laser in addition to exercises. The interventions were received three times/week for four consecutive weeks. The strength of trunk extensors, fatigue, pain, lumbar flexion ROM, and disability were measured at baseline, after 4 weeks, and at a 1-month follow-up. The assessment tools used included isokinetic dynamometry, the visual analogue scale (VAS), the modified Schober test (MST), and the Oswestry Disability Index (ODI). Results: < 0.05). However, fatigue and disability did not differ between the two active laser groups. All groups showed minor changes between the post-treatment and follow-up periods. Conclusion: Patients with CNSLBP may have a short-term benefit from HILA and LILA combined with exercise rather than from exercise alone in terms of trunk extensor strength and fatigue, pain, lumbar flexion ROM, and disability. However, both laser treatments showed comparable effects on fatigue and disability; HILA appears to be more effective than LILA in improving trunk extensor strength and relieving pain. To define the ideal treatment parameters and to evaluate long-term effects, further research is required. Clinical Trial Registration: https://clinicaltrials.gov/, identifier [NCT06280846].

chronic non-specific low back painlaser acupunctureexercise therapytrunk extensor strength
ArticleOpen access20261citation· Semantic Scholar

Efficacy of combined Kinesio-taping with chest physiotherapy program on pain, pulmonary function, respiratory muscle strength and quality of life after mastectomy: a randomized controlled trial

Frontiers in Medicine · vol. 12 · 1664210-1664210

Objectives This study aimed to assess the effects of incorporating Kinesio-taping (KT) into a chest physical therapy program on alleviating pain and enhancing pulmonary function, respiratory muscle strength, and quality of life following mastectomy. Design This was a prospective, randomized controlled trial. Setting Physiotherapy outpatient clinic. Participants Sixty participants aged 30–50 years who had undergone modified radical mastectomy were randomly allocated to either the Kinesio-taping or traditional physical therapy exercise group. Intervention The Kinesio-taping group received both Kinesio-taping and traditional chest physiotherapy. The control group received only the traditional chest physiotherapy program. The interventions were administered over a 4-week period. Outcome measures The primary outcome measure was pain, which was evaluated using a visual analogue scale (VAS). Secondary outcomes included pulmonary function, specifically forced vital capacity (FVC) and forced expiratory volume in one second (FEV1), assessed via spirometry; respiratory muscle strength, determined by measuring maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) using a portable pressure device; and quality of life, assessed using the Short Form-36 (SF-36) questionnaire. All outcomes were measured at baseline and 4 weeks after the intervention. Results The evaluated parameters exhibited significant alterations between the pre- and post-intervention after a duration of 4 weeks in both groups. The results indicated a significant changes ( p < 0.001) in post-intervention measures compared to pre-intervention measures in both groups. No significant differences were observed between the groups before the intervention. The KT group demonstrated superior postintervention outcomes. Specifically, the KT group showed a significant reduction in VAS scores post-intervention than the control group (3.97 ± 1.65 vs. 6.50 ± 1.57, p < 0.001). Post-intervention, the KT group exhibited significantly higher values ( p < 0.001) of FVC, FEV1, and FEV1/FVC (3.52 ± 0.64 L, 2.95 ± 0.56 L, and 85.09 ± 12.07%) compared to the control group (2.38 ± 0.56 L, 1.74 ± 0.54 L, and 72.39 ± 10.82%), respectively. Additionally, post-intervention MIP and MEP values were significantly higher ( p < 0.001) in the KT group. Conclusion Integrating Kinesio-taping into a standard chest physiotherapy program significantly reduced pain and enhanced pulmonary function, respiratory muscle strength, and quality of life in post-mastectomy patients compared to the application of traditional chest physiotherapy alone. Clinical trial registration ClinicalTrials.gov , identifier NCT06701591.

kinesio tapingchest physiotherapymastectomypostoperative pain
ArticleOpen access2026

Tavapadon in Parkinson’s disease: D1/D5 receptor pharmacology, clinical evidence, and translational perspectives

Frontiers in Aging Neuroscience · vol. 18

Tavapadon is an oral, once-daily, non-catechol partial agonist selective for the D1 and D5 dopamine receptors and represents a mechanistically distinct option currently under clinical investigation for Parkinson disease (PD). This narrative review critically evaluates the biological rationale for D1/D5 receptor targeting, the pharmacological and preclinical development of tavapadon, and the accumulating phase 1–3 clinical evidence for its use as monotherapy in early PD and as adjunctive therapy in patients with motor fluctuations, while highlighting remaining evidence gaps and methodological limitations. A non-systematic literature search of PubMed/MEDLINE, Embase, ClinicalTrials.gov , and Scopus (through May 2026) was performed to identify representative and pivotal randomized controlled trials, pharmacokinetic/pharmacodynamic studies, and mechanistic preclinical investigations relevant to tavapadon and D1/D5 receptor agonism; this narrative approach was not intended to be exhaustive or fully reproducible in the manner of a systematic review. Mechanistically, selective stimulation of the direct striatal pathway together with submaximal intrinsic efficacy at the D1 receptor has been proposed, as a mechanistic hypothesis rather than a demonstrated clinical mechanism, to preserve antiparkinsonian benefit while limiting the receptor-signaling intensity implicated in levodopa-induced dyskinesia. In the phase 2 PARKWAY-II study and the now fully published phase 3 TEMPO-1 and TEMPO-2 trials, fixed- and flexible-dose tavapadon produced clinically meaningful improvements in MDS-UPDRS motor scores compared with placebo in early PD, and in the phase 3 TEMPO-3 trial, adjunctive tavapadon significantly increased daily good ON time and reduced OFF time in levodopa-treated patients with motor fluctuations; efficacy in all trials has been demonstrated only against placebo, with no head-to-head data against levodopa or other dopamine agonists. Adverse events were more frequent with tavapadon than placebo (approximately 72–76% versus 55% across TEMPO-2 and TEMPO-3), with nausea, headache, and dizziness the most common; no excess signal of impulse-control disorders relative to placebo was detected over the available 26–27-week controlled treatment period, and no clinically significant QTc prolongation was observed. The 58-week open-label TEMPO-4 extension, now reported in a peer-reviewed AAN abstract publication in Neurology alongside earlier interim conference data, suggests sustained benefit and a stable long-term levodopa requirement, but lacks a randomized control and cannot yet establish long-term safety superiority over existing agents. Tavapadon is a mechanistically novel candidate with preliminary evidence of efficacy; its ultimate clinical utility will depend on head-to-head trials and long-term safety data.

Parkinson's diseasedopamine D1 receptordopamine D5 receptormotor fluctuations
ArticleOpen access2026

A bibliometric analysis of the top 50 most-cited articles in glaucoma management

Medicine · vol. 105 (37) · e50617-e50617

BACKGROUND: As the foremost cause of irreversible vision loss around the world, glaucoma continues to be the leading factor behind irreversible blindness. Even with progress in diagnostic tools, surgical techniques, and additional therapies, the disease continues to be problematic because of its asymptomatic onset and the partial effectiveness of pressure-reducing treatments. The overall role of significant publications in guiding glaucoma research has not been thoroughly evaluated. METHODS: A bibliometric study was carried out to determine the 50 articles on glaucoma with the highest citation counts, with searches conducted in the Web of Science database. Four reviewers independently screened the articles. The extracted information covered authorship, country of origin, journal name, study design, level of evidence, citation counts, and thematic focus. Citation and co-occurrence mapping were applied. RESULTS: The 50 most-cited articles accrued 4054 citations (mean: 81.1), peaking in the 2000s (42%). The US (52%) and UK (30%) led contributions, primarily in Ophthalmology and British Journal of Ophthalmology. Level II evidence predominated (44%), followed by Level IV evidence (38%). Retrospective cohort studies comprised the most common study design (36%), followed by case series (30%), while randomized controlled trials represented 12% of the included studies. Key themes included diagnostic integration, trabeculectomy, minimally invasive surgery (MIGS), and refractory disease management. CONCLUSION: Most-cited glaucoma-management literature was characterized by retrospective study designs and representation of both traditional filtration surgery and emerging device-based approaches, including MIGS. These findings describe patterns of scholarly attention within highly cited glaucoma-management literature and should not be interpreted as trends across the entire field or as evidence of comparative clinical effectiveness.

glaucoma managementhighly cited paperscitation analysisresearch trends
ArticleOpen access2026

Effect of the multimodal vestibular training on balance and quality of life in stroke survivors: a randomized controlled trial

Scientific Reports

Post-stroke balance impairment is multifactorial, and limited evidence is available on whether Multimodal Vestibular Training (MVT) provides additional benefits when added to conventional balance training. This study investigated the effect of a four-week MVT program on balance, functional mobility, and quality of life in chronic stroke survivors. After screening 25 stroke patients, 21 eligible chronic stroke survivors were enrolled. Participants were aged 30–75 years, had stroke duration of at least six months, could walk at least 10 m safely under supervision, had MMSE scores ≥ 24, and had Berg Balance Scale scores > 21. Participants were randomly assigned to the experimental group ( n = 11), which received MVT with conventional balance training, or the control group ( n = 10), which received conventional balance training only. Both groups received three supervised 45-minute sessions per week for four weeks. Outcomes were assessed at baseline and post-intervention using the Timed Up and Go (TUG) test, Berg Balance Score (BBS), and Stroke-Specific Quality of Life questionnaire (SS-QoL). Eighteen participants completed the post-intervention assessment and were included in the final analysis, with nine participants in each group. No significant baseline differences were observed between groups. Post-intervention analysis showed significantly better TUG scores in the experimental group than the control group, ( p = 0.002), and significantly better SS-QoL scores ( p = 0.006). Post-intervention BBS scores did not differ significantly between groups ( p = 0.924). Change-score analysis showed significantly greater improvement in the experimental group for TUG ( p = 0.042), BBS ( p = 0.013), and SS-QoL ( p = 0.023). The findings suggest that MVT, when added to conventional rehabilitation, may be associated with improvements in functional mobility and selected quality-of-life outcomes in chronic stroke survivors. BBS scores improved over time, although the post-intervention between-group difference was not significant. Given the limited sample size and short intervention duration, these findings should be interpreted as preliminary and confirmed in larger adequately powered randomized controlled trials. Trial registration: The study protocol was prospectively registered online in the Clinical Trial Registry India (CTRI) at https//www.ctri.nic.in/ with the identifier CTRI/2023/12/060822 dated 18/12/2023.

chronic strokepost-stroke balance impairmentbalance trainingfunctional mobility
ArticleOpen access2026

Current Evidence and Clinical Controversies in the Management of Complicated Pneumonia in Children

American Journal of Pediatrics · vol. 12 (3) · 87-102

Background: Parapneumonic effusion (PPE) and empyema remain serious complications of childhood pneumonia associated with significant morbidity despite advances in antimicrobial therapy and surgical techniques. Accurate disease staging and timely stage-directed intervention are fundamental to optimal outcomes. Objective: To provide a current, evidence-based synthesis of the definition, etiology, diagnosis, and management of complicated pneumonia in children, with particular focus on areas of ongoing clinical controversy. Methods: A narrative review incorporating randomized controlled trials, systematic reviews, meta-analyses, Cochrane reviews, and international clinical guidelines published between 2016 and 2026 was conducted. PubMed was searched through May 2026 using terms including pneumonia, complicated pneumonia, parapneumonic effusion, empyema, VATS, fibrinolysis, decortication, and pediatric. Results: Chest radiography remains the initial imaging modality for suspected complicated pneumonia, with lateral decubitus views needed to assess pleural fluid mobility. However, chest ultrasonography is the preferred imaging modality for evaluating parapneumonic effusions and empyema because of its superior diagnostic accuracy, ability to characterize pleural collections, and absence of ionizing radiation. Management is stage-dependent, combining targeted antibiotic therapy with procedural intervention when indicated. Image-guided pigtail catheter drainage with intrapleural fibrinolytic therapy is effective for most patients. VATS demonstrates particular utility during the fibrinopurulent stage. No single fibrinolytic agent has demonstrated clear superiority; however, tissue plasminogen activator is most widely employed. Open decortication remains reserved for refractory or advanced-stage disease. Conclusion: Early diagnosis, appropriate antibiotics, and prompt intervention or surgery are all important for optimal care. The optimal outcomes require a multidisciplinary, individualized, stage-directed approach. Interventional radiology is appropriate for single loculations, while early VATS is favored for thick pleural rind or multiple loculations. Further high-quality prospective research is needed to establish definitive treatment algorithms.

complicated pneumoniapediatric pneumoniaparapneumonic effusionempyema
ArticleOpen access2026

Acute effect of whole-body vibration on hand grip strength, muscular activity, and upper limb function in young females with smartphone addiction: a randomized controlled trial

Frontiers in Medicine · vol. 13 · 1800879-1800879

Objective: To assess the efficacy of whole-body vibration (WBV) on hand grip strength, muscular activity, and upper limb function in young females with smartphone addiction. Materials and methods: This is a single-blinded randomized controlled trial. 66 females aged 18-25 years with smartphone addiction were randomly distributed into two equal groups; WBV group: It received WBV with strengthening exercises, and Sham WBV group: that received Sham WBV plus strengthening exercises. All participants received two sessions per week for four consecutive weeks. The primary outcome was hand grip strength. Secondary outcomes included pinch strength, muscle activity, and upper limb function. Evaluation was performed at baseline and after 4 weeks. Results: < 0.001) compared to the Sham WBV group. Mean differences (95% CI) between both groups were 9.48 [7.07, 11.88] for hand grip strength, which is the primary outcome. Conclusion: WBV combined with hand strengthening exercises might have a positive effect in enhancing hand grip strength, pinch strength, muscle activity, and upper limb function among young females with smartphone addiction. WBV could be a valuable adjunct to traditional rehabilitation programs targeting musculoskeletal effects of smartphone overuse. Clinical trial registration: ClinicalTrials.gov, identifier: NCT06849687.

whole-body vibrationsmartphone addictiongrip strengthpinch strength
ArticleOpen access2026

Efficacy and Safety of Icotrokinra (an Interleukin-23 Inhibitor) in the Management of Moderate-to-Severe Plaque Psoriasis: A Systematic Review and Meta-Analysis

JMA Journal · vol. 9 (5) · 1397-1405

Background: Plaque psoriasis, which is a chronic immune-mediated inflammatory skin condition, significantly reduces patients' quality of life. The cytokine interleukin-23 (IL-23) is a pivotal factor in the development of psoriasis, and icotrokinra is a new oral IL-23 receptor antagonist that has shown potential effectiveness in clinical trials. The main goal of this systematic review and meta-analysis was to assess the effectiveness and safety of icotrokinra in adults and adolescents with moderate-to-severe plaque-type psoriasis. Methods: A comprehensive literature search in PubMed, ScienceDirect, and the Cochrane Library, conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) standards, identified randomized controlled trials that evaluated daily oral icotrokinra 200 mg versus placebo. The primary outcomes were Psoriasis Area and Severity Index (PASI) 90, Investigator's Global Assessment (IGA) 0/1, and adverse events (AEs) at 16 weeks. Risk ratios with 95% confidence intervals were summed up through a random-effects model. Results: A total of five randomized controlled trials involving 2,755 participants were included. Icotrokinra showed a significant increase in PASI 90, IGA 0/1, IGA 0, and Psoriasis Symptoms and Signs Diary 0 responses compared to placebo. The overall frequency of AEs was similar in both groups, but the rate of treatment discontinuation due to AEs was lower with icotrokinra. Conclusions: Icotrokinra is an effective and well-tolerated oral treatment for moderate-to-severe plaque psoriasis with considerable clinical and patient-reported benefits.

IL-23 inhibitorsplaque psoriasismoderate-to-severe psoriasisefficacy
ArticleOpen access20258citation· Semantic Scholar

Transforming neonatal nursing: a randomized controlled trial comparing kangaroo care and standard protocols for survival in preterm infants with respiratory distress syndrome

BMC Nursing · vol. 24 (1) · 430-430

BACKGROUND: Respiratory Distress Syndrome (RDS) remains a leading cause of mortality among preterm infants weighing < 2000 g, particularly in resource-limited settings. While Kangaroo Mother Care (KMC) has shown promise in stable preterm infants, its effectiveness for those requiring respiratory support remains unclear. This study evaluated nurse-led implementation of KMC for preterm infants with RDS. METHODS: A prospective, multicenter, randomized controlled trial was conducted across four neonatal intensive care units in Tanta, Egypt (January 2023-June 2024). Two hundred forty preterm infants (<2000 g) with RDS were randomly assigned to either nurse-implemented KMC (n = 120) or standard care (n = 120). The KMC protocol, implemented for a minimum of 6 h per day until hospital discharge, integrated continuous skin-to-skin contact, exclusive breastfeeding promotion, and structured parental education. Outcomes included 28-day survival, respiratory status (Silverman-Anderson Scores), nosocomial infections, maternal-infant bonding, growth trajectories, and clinical course metrics. RESULTS: The KMC intervention significantly improved 28-day survival (adjusted HR = 0.42, 95% CI 0.28-0.63, p < 0.001) and reduced nosocomial infections by 55% (RR = 0.45, 95% CI 0.27-0.75, p < 0.001). KMC recipients demonstrated faster respiratory improvement, shorter CPAP duration (-2.2 days, p < 0.001), and higher rates of exclusive breastfeeding at discharge (74.2% vs. 48.3%, p < 0.001). Maternal competency scores showed progressive improvement with enhanced bonding and responsiveness. CONCLUSION: Nurse-implemented KMC is a safe, effective intervention for preterm infants with RDS, yielding significant improvements in survival, clinical outcomes, and family-centered care metrics. IMPLICATIONS FOR PRACTICE: These findings support the expansion of nursing roles in implementing KMC for high-risk infants in resource-limited settings. TRIAL REGISTRATION: ClinicalTrials.gov (NCT06707376).

kangaroo mother carerespiratory distress syndromepreterm infantsneonatal nursing
ArticleOpen access20256citation· Semantic Scholar

Nurse-led telemedicine versus in-person lactation support for breastfeeding initiation in mothers of low-birth-weight infants: a non-inferiority randomized controlled trial

BMC Pregnancy and Childbirth · vol. 25 (1) · 1066-1066

BACKGROUND: Early breastfeeding initiation is crucial for low-birth-weight (LBW) infants, yet in-person lactation support may be limited in resource-poor settings. Telemedicine holds promise but lacks robust comparative evidence with traditional care. OBJECTIVE: To evaluate whether nurse-led telemedicine is non-inferior to in-person support on routine early-initiation performance in LBW/NICU settings, and to describe breastfeeding processes within 24 h postpartum. METHODS: This parallel-group, non-inferiority randomized controlled trial included 200 mothers of LBW infants admitted to four neonatal intensive care units (NICUs) in Egypt. Participants were randomized (1:1) to receive nurse-led telemedicine or standard in-person lactation support. Primary Process Outcome: Direct Breastfeeding Initiation within 1 Hour, assessed against a 5% non-inferiority margin. Secondary outcomes of maternal self-efficacy, satisfaction, state anxiety, and infant growth parameters were measured at baseline, one week, and one month postpartum. Analyses followed both intention-to-treat and per-protocol approaches. RESULTS: Breastfeeding initiation occurred in 65% of mothers in the telemedicine group versus 70% in the in-person group, confirming non-inferiority (p = 0.04). Although in-person support provided a minor short-term advantage in maternal self-efficacy at one week (49.2 ± 6.5 vs. 47.5 ± 7.2, p = 0.03), scores converged by one month (p = 0.45). Telemedicine participants reported higher satisfaction with accessibility (p = 0.03), while overall support quality, anxiety reduction, and infant growth measures were comparable between groups. Parity and socioeconomic status independently predicted breastfeeding initiation (p < 0.01). CONCLUSIONS: Nurse-led telemedicine did not reduce first-hour initiation relative to in-person support; given stabilization protocols in LBW/NICU care, this endpoint functions as a process benchmark rather than a direct target of the support modality. Although in-person support may offer early advantages in maternal self-efficacy, telemedicine effectively sustains key outcomes over time and can expand equitable breastfeeding support in regions with limited healthcare resources. TRIAL REGISTRATION: ClinicalTrials.gov NCT06652386, Registered 22 October 2024.

breastfeeding initiationtelemedicinenurse-led carebreastfeeding support
ArticleOpen access20255citation· Semantic Scholar

Comparing the Therapeutic Impact of Strain-Counterstrain and Exercise on Low Back Myofascial Pain Syndrome: A Randomized Trial

Journal of Multidisciplinary Healthcare · vol. Volume 18 · 1-12

Background: Background: Strain-Counterstrain (SCS) therapy is a manual therapeutic technique used to treat myofascial pain by addressing tender points through passive positioning. Despite anecdotal evidence, limited peer-reviewed research supports its efficacy in chronic low back pain (LBP). This study evaluates the effects of SCS combined with exercise on pain severity, lumbar range of motion (ROM), and functional disability in patients with chronic LBP. Methods: A randomized controlled trial was conducted with 30 participants aged 45-55 years, divided into Group A (SCS + Exercise) and Group B (Exercise Only). Outcome measures included pain intensity, lumbar ROM (flexion, extension, side bending), and functional disability (Oswestry Disability Index). Assessments were conducted at baseline and after four weeks of intervention. MANOVA was performed to evaluate group, time, and interaction effects, with detailed univariate follow-ups and effect sizes. Reliability of ROM measurements was ensured using intraclass correlation coefficients (ICC > 0.90). Results: MANOVA revealed statistically significant group, time, and interaction effects for all outcomes (Wilks' Lambda = 0.065, F (6, 51) = 91.34, p < 0.001). Pain severity decreased by 26.7% in Group A compared to 5.2% in Group B (F (1, 56) = 65.78, p < 0.001, partial η² = 0.77). Lumbar ROM improved significantly in Group A for flexion (10.9%), extension (20.3%), and right-side bending (17.7%) (p < 0.001, partial η² = 0.68-0.74), with no significant improvement in left-side bending. Functional disability scores reduced by 25.2% in Group A versus 2.3% in Group B (F (1, 56) = 53.45, p < 0.001, partial η² = 0.73). Conclusion: SCS therapy combined with exercise significantly reduces pain, improves lumbar ROM, and enhances functional capacity in patients with chronic LBP compared to exercise alone. These findings highlight SCS as a promising adjunctive treatment for managing chronic musculoskeletal pain. Future studies should investigate long-term outcomes and further refine treatment protocols.

chronic low back painmyofascial pain syndromeexercise therapylumbar range of motion
ArticleOpen access20252citation· Semantic Scholar

Efficacy of ankle Kinesio taping on balance and functional performance in obese female collegiate students: a prospective randomized placebo-controlled trial

Frontiers in Public Health · vol. 13 · 1631757-1631757

Objective: This study aimed to evaluate the efficacy of ankle Kinesio taping (KT) on static and dynamic balance and functional performance in obese female collegiate students. Design: This study was a prospective, randomized controlled trial. Setting: The research was conducted in outpatient physical therapy settings. Participants: A total of 40 female collegiate students, aged 18-25 years, were randomly assigned to two groups of equal size. Intervention: Group A (KT group) received KT with 75-100% tension, and group B (Placebo KT group) received placebo KT with 0% tension. KT was applied to the dominant leg in both groups for 6 weeks. Outcome measures: The primary outcome was static balance, which was measured using the single-leg stance test (SLST). The secondary outcomes were dynamic balance, assessed using the Biodex Balance System (BBS), and functional performance, which was assessed using the single-leg vertical jump test (SLVJT) and single-leg hop test (SLHT). All outcomes were assessed at baseline and after 6 weeks. Results: < 0.001) in the KT group compared to the control group after a period of 6 weeks. Conclusion: The application of a 6-week KT mechanical correction technique can improve static and dynamic balance and functional performance in obese female university students compared to the placebo group. Including KT in the treatment plan is recommended for obese women with balance and functional performance deficits. Clinical trial registration: ClinicalTrials.gov, identifier NCT06195748.

kinesio tapingankle tapingobesityfemale university students
ArticleClosed20251citation· Semantic Scholar

Evaluating the Efficacy of Mindfulness-Based Cognitive Therapy in Alleviating Depressive Symptoms, Reducing Rumination, and Preventing Relapse Among the Institutionalized Patients in Nigeria: A Randomized Controlled Trial

International Journal of Social Psychiatry · vol. 72 (5) · 1225-1238

Background: Depression is a serious issue in the world, affecting over 350 million people. Although it may present at any age, adolescence to early adulthood is the most common age of onset, and females are affected twice as much as males. Rumination is a specific known risk factor for the onset, severity, prolongation, and relapse of depression. Relapse prevention in recurrent depression is a significant public health problem, and antidepressants are the current first-line treatment approach. Aim: This study aims to evaluate the efficacy of mindfulness-based cognitive therapy in alleviating depressive symptoms, reducing rumination, and preventing relapse among depressive patients. Method: This randomized controlled trial was conducted with 101 population of 101 consisting of adult patients with three or more previous episodes. Participants were randomly assigned to Mindfulness-Based Cognitive Therapy ( n = 50) and Control Group ( n = 51) using randomized sampling. The Mindfulness-Based Cognitive Therapy group received 8-week group training sessions including meditation exercises, psycho-education and group discussions. The assessment was done at baseline, post-treatment, and 2-month follow-up. Analysis was done using SPSS software (V 22). Result: The results showed that there were no significant differences between the groups on depression relapse (χ 2 = 0.002; p = 0.99). However, there is a statistically significant reduction in depressive symptoms mean score level in the MBCT group [ F (2, 37) = 6.878, p = .003]. Moreover, there is a statistically significant reduction in rumination score in the MBCT group [F (2,37) = 36.021; p = 0.02]. Conclusion: The findings showed that MBCT appears efficacious in reducing depressive symptoms and rumination. However, MBCT did not further reduce their risk for relapse/recurrence.

mindfulness-based cognitive therapydepressiondepressive symptomsrumination
ArticleOpen access20251citation· Semantic Scholar

Effectiveness of Electromagnetic Field Therapy in Mechanical Low Back Pain: A Randomized Controlled Trial

Journal of Pain Research · vol. Volume 18 · 1131-1142

Background: Between half and three quarters of the working-age population in today's industrialized globe suffers from lower back pain. The presence of a myofascial trigger point-a hyperirritable painful area comprised of a small number of muscle fibers-identifies mechanical back pain sufferers as suffering from myofascial pain syndrome, a chronic pain disorder. This research objectives to determine whether mechanical back pain patients' pain severity and functional disabilities are influenced by electromagnetic field therapy. Methods and Subjects: Two groups of thirty patients were randomly assigned. The 15 participants in group A underwent conventional physical therapy (including ultrasound, stretches, and strength training for the back muscles), while the 15 participants in group B received a combination of conventional physical therapy and electromagnetic field therapy. Pre- and post-treatment assessments of pain intensity, functional impairment, and lumbar range of motion (including extension, flexion, and right and left side bending) were examined. The variables of interest that were examined at various testing groups and measuring periods were compared using a 2×2 mixed design MANOVA. Results: After treatment, there was a significant difference in all dependent variables between the two groups in terms of between-subject effects (p <0.05). Group B benefited from a significant decrease in pain, right and left side bending, and function disability, as well as an increase in flexion and extension. Conclusion: Patients suffering from mechanical back pain can find relief from their discomfort and functional impairment through the use of electromagnetic field therapy, according to the current study's conclusions.

electromagnetic field therapymechanical low back painmyofascial trigger pointsmyofascial pain syndrome